https://www.zacks.com/stock/news/2212995/here-s-why-cme-group-cme-deserves-a-spot-in-your-portfolio?cid=CS-ZC-FT-analyst_blog|rank_focused-2212995
Jan 19, 2024 - CME Group's (CME) global presence, compelling product portfolio, focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
zc:3668767186749583050
0
https://www.zacks.com/stock/news/2213576/what-s-in-store-for-progressive-pgr-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213576
Jan 22, 2024 - Progressive's (PGR) fourth-quarter earnings are likely to have benefited from improved rates, solid policies in force and higher retention in its strong Vehicle and Property businesses.
zc:-6006315287960220498
0
https://www.zacks.com/stock/news/2213662/is-a-beat-in-store-for-marsh-mclennan-mmc-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213662
Jan 22, 2024 - Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect robust international operations in the Risk and Insurance Services unit.
zc:583764861592681941
0
https://www.zacks.com/stock/news/2218351/chubb-cb-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2218351
Jan 30, 2024 - Chubb (CB) delivered earnings and revenue surprises of 63.71% and 3.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-2235740297565565894
0
https://www.zacks.com/stock/news/2218383/chubb-cb-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2218383
Jan 30, 2024 - Although the revenue and EPS for Chubb (CB) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-3013718258673775405
0
https://www.zacks.com/commentary/2219543/top-research-reports-for-abbott-t-mobile-booking?cid=CS-ZC-FT-research_daily-2219543
Feb 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).
zc:-2929895383254301058
0
https://www.zacks.com/commentary/2232860/top-research-reports-for-nvidia-visa-amgen?cid=CS-ZC-FT-research_daily-2232860
Feb 28, 2024 - Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Visa Inc. (V) and Amgen Inc. (AMGN).
zc:3063361431494597975
0
https://www.zacks.com/stock/news/2234150/why-are-prudent-investors-favoring-amerisafe-amsf-shares-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2234150
Feb 29, 2024 - AMERISAFE's (AMSF) cost-saving initiatives are expected to drive bottom-line growth.
zc:-5428162455455749691
0
https://www.zacks.com/stock/news/2244406/chubb-cb-shares-rise-21-in-6-months-will-the-bull-run-stay?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2244406
Mar 21, 2024 - A compelling portfolio, strong renewal retention, positive rate increases, strategic initiatives to fuel profitability and solid capital position continue to drive Chubb (CB).
zc:-1539087523064068212
0
https://www.zacks.com/commentary/2249049/top-analyst-reports-for-alphabet-oracle-chevron?cid=CS-ZC-FT-research_daily-2249049
Apr 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Oracle Corporation (ORCL) and Chevron Corporation (CVX).
zc:117571933160202768
0